Tech Company Financing Transactions

Arresto Biosciences Funding Round

On 3/3/2009, Arresto Biosciences announced Series C funding from private investors.

Transaction Overview

Announced On
3/3/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3183 Porter Dr.
Palo Alto, CA 94304
USA
Email Address
Not Recorded
Overview
Arresto BiosciencesTM is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins.
Profile
Arresto Biosciences LinkedIn Company Profile
Social Media
Arresto Biosciences Company Twitter Account
Company News
Arresto Biosciences News
Facebook
Arresto Biosciences on Facebook
YouTube
Arresto Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Vlasselaer
  Peter Vlasselaer LinkedIn Profile  Peter Vlasselaer Twitter Account  Peter Vlasselaer News  Peter Vlasselaer on Facebook
Vice President
Dung Thai
  Dung Thai LinkedIn Profile  Dung Thai Twitter Account  Dung Thai News  Dung Thai on Facebook
VP - R & D
Victoria Smith
  Victoria Smith LinkedIn Profile  Victoria Smith Twitter Account  Victoria Smith News  Victoria Smith on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/2/2009: CashStar venture capital transaction
Next: 3/3/2009: Zayo Group venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary